Tuesday , June 19 2018
Home / Letter From The Editor (page 31)

Letter From The Editor

November 12, 2015

There are many studies going on looking at the side effects of medications for every disease state. Most of these occur after the drugs are on the market and more people are using them. One of the problems that can occur in these postmarking studies is the lack of good controls …

Read More »

November 7, 2015

Oftentimes when an insulin using patient is admitted to the hospital they are kept on the same insulin product and regimen they arrived with. For many patients this works well but for those using mixed insulin there appears to be an increased incidence of hypoglycemia. This could be because of …

Read More »

Each week we try to bring you the latest in diabetes care, and some of you often email me about the Homerun Slides and how they often explore therapies with drugs that are not available to use in practice. This week’s Slides look at studies using a yet-to-be-approved GLP-1 analog …

Read More »

October 31, 2015

There has been a lot of press concerning the use of SGLT-2 Inhibitors and the possibility of DKA. Logically speaking it would seem that anything that lowers glucose would be of benefit in preventing DKA, but for some reason the human body seems to defy logic. With this in mind …

Read More »

This week the riders from Team NovoNordisk are competing in the Tour of Hainan. We have an exclusive interview with Dutch rider, Martijn Verschoor, regarding what he likes to eat before a race and how he maximizes his potential. Martijn’s regimen must be working because he has had 2 top 10 finishes in the …

Read More »

October 24, 2015

Many of you were probably aware that 10/20/15 was “Back to the Future Day,” the date that Doc Brown set for Marty McFly to go to the future. There were all kinds of programs and advertisements for this day. In Saint Petersburg you could get 1 year for $20 at …

Read More »

Early-on in DPP-4 Inhibitor drug development there was a product ready to go before Januvia. The pills were in the bottle, the booth was ready to go at ADA and then the drug was withdrawn from the market, because of reports of skin lesions. The word on the street indicated …

Read More »

This week our Home Run Slides lay out a roadmap for insulin intensification, and the use of GLP-1 analogs and DPP4-I with insulin. If you follow the path your patients can safely intensify therapy with a greatly reduced risk of hypoglycemia. You can learn even more about all the different …

Read More »

October 17, 2015

Last Friday, I had my six interns gather at a local restaurant for an insulin sit-down. We ran some scenarios for converting patients from basal insulin to mixed insulins, and for adding mealtime insulins. As they were offering their answers, it became very apparent that they were not well-versed in …

Read More »

Editor’s Note We all have heard about the value of the  Mediterranean Diet for our CV patients. In addition clinicians often advise patients to use this food plan to reduce LDL, weight and glucose levels. What is it about these food choices that cause improvements in CV outcomes? This week our …

Read More »